The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease

BACKGROUND: To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR) < 30 mL/min per 1.73 m(2). METHODS: In this cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yuan, Wang, Te-Hsiung, Tsai, Ming-Lung, Wu, Victor Chien-Chia, Tseng, Chin-Ju, Lin, Ming-Shyan, Li, Yan-Rong, Chang, Chih-Hsiang, Chou, Tien-Shin, Tsai, Tzu-Hsien, Yang, Ning-I, Hung, Ming-Jui, Chen, Tien-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024371/
https://www.ncbi.nlm.nih.gov/pubmed/36932379
http://dx.doi.org/10.1186/s12933-023-01793-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024371/
https://www.ncbi.nlm.nih.gov/pubmed/36932379
http://dx.doi.org/10.1186/s12933-023-01793-9

Ejemplares similares